Workflow
QFII持股
icon
Search documents
梦百合跌2.06%,成交额5791.51万元,主力资金净流出667.69万元
Xin Lang Cai Jing· 2025-11-18 05:31
Core Viewpoint - The stock of Dream Lily has experienced fluctuations, with a recent decline of 2.06% and a year-to-date increase of 34.78%, indicating volatility in its market performance [1][2]. Group 1: Stock Performance - As of November 18, Dream Lily's stock price is 9.03 CNY per share, with a total market capitalization of 5.152 billion CNY [1]. - The stock has seen a net outflow of 6.6769 million CNY in principal funds, with significant selling pressure from large orders [1]. - Over the past five trading days, the stock has decreased by 3.22%, while it has increased by 7.12% over the past 60 days [1]. Group 2: Company Overview - Dream Lily, established on May 30, 2003, and listed on October 13, 2016, specializes in home products aimed at enhancing deep sleep, including memory foam mattresses and pillows [2]. - The revenue composition includes memory foam mattresses (52.06%), sofas (13.12%), and other products, indicating a diverse product range [2]. - As of September 30, the company had 24,100 shareholders, with an average of 23,651 circulating shares per shareholder [2]. Group 3: Financial Performance - For the period from January to September 2025, Dream Lily reported a revenue of 6.756 billion CNY, reflecting a year-on-year growth of 10.29%, and a net profit of 161 million CNY, marking a significant increase of 205.18% [2]. - The company has distributed a total of 546 million CNY in dividends since its A-share listing, with 28.5293 million CNY in the last three years [3]. Group 4: Institutional Holdings - As of September 30, 2025, major institutional shareholders include Hua'an Ankang Flexible Allocation Mixed Fund and others, with some institutions reducing their holdings while new ones have entered [3].
深康佳A跌2.17%,成交额1.08亿元,主力资金净流出2343.50万元
Xin Lang Cai Jing· 2025-11-18 03:20
Core Viewpoint - The stock of Deep Konka A has experienced a decline in price and significant net outflow of funds, indicating potential challenges in market performance and investor sentiment [1][2]. Financial Performance - For the period from January to September 2025, Deep Konka A reported a revenue of 7.679 billion yuan, a year-on-year decrease of 5.43%, while the net profit attributable to shareholders was -982 million yuan, reflecting a year-on-year increase of 38.89% [2]. - The company has cumulatively distributed 2.557 billion yuan in dividends since its listing, with no dividends paid in the last three years [3]. Stock Market Activity - As of November 18, Deep Konka A's stock price was 5.42 yuan per share, with a market capitalization of 13.051 billion yuan. The stock has declined by 1.81% year-to-date and 3.90% over the last five trading days [1]. - The stock has appeared on the "龙虎榜" (a list of stocks with significant trading activity) five times this year, with the most recent appearance on April 15, where it recorded a net buy of 123 million yuan [1]. Shareholder Information - As of September 30, 2025, the number of shareholders for Deep Konka A was 146,700, a decrease of 3.33% from the previous period [2]. - The largest circulating shareholder is Hong Kong Central Clearing Limited, holding 12.7781 million shares, an increase of 1.8757 million shares from the previous period [3].
弘业期货跌2.07%,成交额5549.24万元,主力资金净流出811.43万元
Xin Lang Cai Jing· 2025-11-18 03:01
Core Viewpoint - 弘业期货's stock price has shown a year-to-date increase of 13.19%, but has recently experienced declines over various time frames, indicating potential volatility in its market performance [2]. Group 1: Stock Performance - As of November 18, 弘业期货's stock price decreased by 2.07% to 10.90 CNY per share, with a total market capitalization of 10.985 billion CNY [1]. - The stock has seen a decline of 1.27% over the last 5 trading days, 2.33% over the last 20 days, and 18.84% over the last 60 days [2]. - The company has appeared on the龙虎榜 (a stock trading leaderboard) 8 times this year, with the most recent appearance on July 14, where it recorded a net buy of 24.6763 million CNY [2]. Group 2: Financial Performance - For the period from January to September 2025, 弘业期货 reported zero operating revenue and a net profit attributable to shareholders of 2.0897 million CNY, reflecting a year-on-year decrease of 87.27% [3]. - Cumulative cash dividends since the A-share listing amount to 44.3422 million CNY [4]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders decreased by 13.10% to 54,400, with an average of 0 circulating shares per shareholder [3]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which holds 2.8647 million shares, a decrease of 3.2006 million shares from the previous period [4].
伊戈尔涨2.02%,成交额2.49亿元,主力资金净流入179.61万元
Xin Lang Zheng Quan· 2025-11-18 02:34
Core Insights - Igor's stock price increased by 2.02% on November 18, reaching 28.83 CNY per share, with a total market capitalization of 12.198 billion CNY [1] - The company has seen a year-to-date stock price increase of 64.54%, but a recent decline of 6.85% over the last five trading days [1][2] - Igor's main business involves the research, production, and sales of power supply products for both consumer and industrial sectors, with energy products accounting for 74.43% of revenue [1] Financial Performance - For the period from January to September 2025, Igor reported a revenue of 3.808 billion CNY, representing a year-on-year growth of 17.41%, while net profit attributable to shareholders decreased by 15.38% to 178 million CNY [2] - Cumulative cash dividends since the A-share listing amount to 475 million CNY, with 308 million CNY distributed over the last three years [3] Shareholder Information - As of October 31, 2025, the number of Igor's shareholders decreased by 28.74% to 28,700, while the average number of circulating shares per person increased by 40.33% to 13,056 shares [2] - Notable institutional shareholders include Hong Kong Central Clearing Limited as the second-largest shareholder with 7.6861 million shares, and several new institutional investors have entered the top ten shareholders list [3]
京能热力跌2.02%,成交额1.18亿元,主力资金净流出502.06万元
Xin Lang Zheng Quan· 2025-11-18 02:29
Core Viewpoint - 京能热力's stock price has shown volatility with a year-to-date increase of 26.25%, but recent trading indicates a mixed performance in the short term [1][2]. Group 1: Stock Performance - On November 18, 京能热力's stock fell by 2.02%, trading at 12.61 CNY per share with a total market capitalization of 3.325 billion CNY [1]. - The stock has experienced a 5.00% increase over the last five trading days, a 3.15% decrease over the last 20 days, and a 7.96% increase over the last 60 days [1]. - The company has appeared on the龙虎榜 twice this year, with the most recent appearance on October 21, where it recorded a net buy of -71.5091 million CNY [1]. Group 2: Financial Performance - For the period from January to September 2025, 京能热力 reported a revenue of 832 million CNY, reflecting a year-on-year growth of 24.03%, and a net profit attributable to shareholders of 57.8386 million CNY, up 35.57% year-on-year [2]. - The company's main revenue sources are heat supply services (84.67%), engineering income (14.43%), and other income (0.90%) [1]. Group 3: Shareholder Information - As of October 31, 京能热力 had 31,000 shareholders, an increase of 30.74% from the previous period, with an average of 6,542 circulating shares per shareholder, a decrease of 23.51% [2]. Group 4: Dividend Information - 京能热力 has distributed a total of 109 million CNY in dividends since its A-share listing, with 56.7029 million CNY distributed over the last three years [3].
哈三联涨2.34%,成交额5242.42万元,主力资金净流出140.38万元
Xin Lang Zheng Quan· 2025-11-18 02:05
Company Overview - Harbin Sanlian Pharmaceutical Co., Ltd. is located in Harbin, Heilongjiang Province, established on June 21, 1996, and listed on September 22, 2017. The company specializes in the research, production, and sales of chemical drug formulations [1][2]. Financial Performance - As of November 10, 2023, Harbin Sanlian reported a revenue of 581 million yuan for the period from January to September 2025, a year-on-year decrease of 30.75%. The net profit attributable to the parent company was -209 million yuan, a significant decline of 614.61% [2]. - The company has cumulatively distributed 677 million yuan in dividends since its A-share listing, with 158 million yuan distributed over the past three years [3]. Stock Performance - On November 18, 2023, Harbin Sanlian's stock price increased by 2.34%, reaching 14.89 yuan per share, with a trading volume of 52.42 million yuan and a turnover rate of 2.05%. The total market capitalization stood at 4.711 billion yuan [1]. - Year-to-date, the stock price has risen by 54.30%, with a 2.69% increase over the last five trading days and a 12.12% increase over the last 20 days. However, it has seen a decline of 1.72% over the past 60 days [1]. Shareholder Information - As of November 10, 2023, the number of shareholders for Harbin Sanlian was 39,600, a decrease of 2.98% from the previous period. The average number of circulating shares per person increased by 3.07% to 4,419 shares [2]. Business Segmentation - The main revenue sources for Harbin Sanlian include: large-volume injections (32.00%), lyophilized powder injections (18.39%), solid preparations (17.39%), small-volume injections (14.34%), and other segments such as veterinary drugs (2.55%) and import/export trade (1.82%) [1].
航宇微跌2.03%,成交额5376.97万元,主力资金净流出760.37万元
Xin Lang Cai Jing· 2025-11-18 01:55
Core Viewpoint - The stock of Hangyu Micro dropped by 2.03% on November 18, with a current price of 14.00 CNY per share and a market capitalization of 9.756 billion CNY, indicating a mixed performance in recent trading periods [1]. Group 1: Financial Performance - As of September 30, 2025, Hangyu Micro reported a revenue of 203 million CNY, a year-on-year decrease of 0.45%, and a net profit attributable to shareholders of -72.49 million CNY, down 18.19% year-on-year [2]. - The company has cumulatively distributed 87.79 million CNY in dividends since its A-share listing, with no dividends paid in the last three years [3]. Group 2: Stock and Market Activity - The stock price has increased by 6.95% year-to-date, but has seen a decline of 2.17% over the last five trading days and a 2.10% drop over the last 60 days [1]. - The stock's trading volume on November 18 was 53.77 million CNY, with a turnover rate of 0.59% [1]. - The number of shareholders as of September 30, 2025, was 77,400, an increase of 1.03% from the previous period, while the average circulating shares per person decreased by 1.02% to 8,410 shares [2]. Group 3: Business Overview - Hangyu Micro, established on March 20, 2000, and listed on February 11, 2010, operates in the aerospace electronics, satellite and satellite big data, and artificial intelligence sectors [1]. - The company's main revenue sources include SIP chips (37.48%), smart security and transportation (26.74%), satellite data and applications (13.74%), geographic information and smart surveying (11.70%), AI chips and algorithms (6.86%), SOC chips (2.36%), EMBC (0.68%), and other business revenues (0.42%) [1].
金龙机电涨2.07%,成交额1.14亿元,主力资金净流入1022.18万元
Xin Lang Zheng Quan· 2025-11-17 06:22
Core Viewpoint - Jinlong Electromechanical has shown a positive stock performance with a year-to-date increase of 20.40%, indicating strong market interest and potential growth opportunities in the electronic components sector [1][2]. Group 1: Stock Performance - On November 17, Jinlong Electromechanical's stock rose by 2.07%, reaching 5.43 CNY per share, with a trading volume of 114 million CNY and a turnover rate of 2.63%, resulting in a total market capitalization of 4.361 billion CNY [1]. - The stock has experienced a 3.82% increase over the last five trading days, a 13.60% increase over the last 20 days, and a slight 0.37% increase over the last 60 days [1]. - The company has appeared on the "Dragon and Tiger List" once this year, with the most recent appearance on May 8, where it recorded a net purchase of 68.7741 million CNY [1]. Group 2: Company Overview - Jinlong Electromechanical, established on November 11, 1993, and listed on December 25, 2009, is located in Dongguan, Guangdong Province, and specializes in the R&D, production, and sales of motors, silicone plastic structural components, and touch display products [2]. - The company's revenue composition includes structural components (48.45%), touch display modules (39.14%), motors (10.31%), electronic atomizers and related accessories (1.16%), and other (0.95%) [2]. - As of September 30, the number of shareholders was 41,600, a decrease of 9.11% from the previous period, with an average of 19,327 circulating shares per person, an increase of 10.03% [2]. Group 3: Financial Performance - For the period from January to September 2025, Jinlong Electromechanical achieved a revenue of 1.212 billion CNY, representing a year-on-year growth of 14.32%, while the net profit attributable to the parent company was 29.6625 million CNY, reflecting a significant year-on-year increase of 149.28% [2].
天目药业跌2.01%,成交额4634.13万元,主力资金净流入37.99万元
Xin Lang Zheng Quan· 2025-11-17 06:10
Core Viewpoint - Tianmu Pharmaceutical's stock has experienced significant fluctuations, with a year-to-date increase of 111.50%, but a recent decline in the last five trading days [1][2]. Financial Performance - For the period from January to September 2025, Tianmu Pharmaceutical achieved a revenue of 159 million yuan, representing a year-on-year growth of 27.48%. The net profit attributable to the parent company was 14.21 million yuan, showing a substantial increase of 484.48% compared to the previous year [2]. Stock Market Activity - As of November 17, Tianmu Pharmaceutical's stock price was 18.57 yuan per share, with a market capitalization of 2.261 billion yuan. The stock saw a trading volume of 46.34 million yuan and a turnover rate of 2.04% [1]. - The company has appeared on the "Dragon and Tiger List" twice this year, with the most recent instance on August 21, where it recorded a net buy of -55.03 million yuan [1]. Shareholder Information - As of September 30, the number of shareholders for Tianmu Pharmaceutical was 9,693, a decrease of 6.91% from the previous period. The average circulating shares per person increased by 7.42% to 12,557 shares [2]. Business Composition - Tianmu Pharmaceutical's main business revenue composition includes health products (48.01%), circulation goods (23.21%), raw materials (15.98%), traditional Chinese medicine (11.47%), Western medicine (0.89%), training (0.32%), and other (0.12%) [1]. Dividend History - Since its A-share listing, Tianmu Pharmaceutical has distributed a total of 59.63 million yuan in dividends, with no dividends paid in the last three years [3].
金海高科跌2.06%,成交额2328.14万元,主力资金净流出273.90万元
Xin Lang Zheng Quan· 2025-11-17 05:21
11月17日,金海高科盘中下跌2.06%,截至13:14,报12.83元/股,成交2328.14万元,换手率0.76%,总 市值30.26亿元。 机构持仓方面,截止2025年9月30日,金海高科十大流通股东中,大成中证360互联网+指数A (002236)位居第五大流通股东,持股150.07万股,相比上期增加11.77万股。诺安多策略混合A (320016)位居第六大流通股东,持股142.53万股,为新进股东。 金海高科所属申万行业为:家用电器-家电零部件Ⅱ-家电零部件Ⅲ。所属概念板块包括:小盘、QFII持 股、节能环保、家用电器、PM2.5等。 截至9月30日,金海高科股东户数1.47万,较上期减少5.68%;人均流通股15997股,较上期增加6.02%。 2025年1月-9月,金海高科实现营业收入6.69亿元,同比增长10.49%;归母净利润7656.26万元,同比增 长50.49%。 分红方面,金海高科A股上市后累计派现2.79亿元。近三年,累计派现7548.29万元。 资金流向方面,主力资金净流出273.90万元,大单买入206.82万元,占比8.88%,卖出480.72万元,占比 20.65%。 金 ...